July 18, 2024
|
Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event
|
July 8, 2024
|
Biora Therapeutics to Host Virtual KOL Event on NaviCap™ Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024
|
July 1, 2024
|
Biora Therapeutics Announces Positive Clinical Trial Results for BT-600
|
June 11, 2024
|
Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024
|
May 20, 2024
|
Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024
|
May 15, 2024
|
Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
|
May 7, 2024
|
Biora Therapeutics to Report First Quarter 2024 Financial Results and Provide Corporate Update
|
May 6, 2024
|
Biora Therapeutics to Present Clinical Data on Device Function of the NaviCap™ Oral Delivery Platform at Digestive Disease Week 2024
|
April 30, 2024
|
Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600
|
April 8, 2024
|
Biora Therapeutics Announces New Patent Covering its BioJet™ Liquid Jet Delivery Technology
|